A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Mayo Clinic
University of Alabama at Birmingham
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Thomas Jefferson University
University of Pittsburgh
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
Stanford University
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
University of Wisconsin, Madison
University of Wisconsin, Madison
Virginia Commonwealth University
Northwestern University
Northwestern University
Mayo Clinic
Case Comprehensive Cancer Center
Swiss Cancer Institute
City of Hope Medical Center
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
University of California, San Francisco
Massachusetts General Hospital
University of Louisville
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
City of Hope Medical Center
Indiana University
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Boston Medical Center
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center